I give all those statistics and epidemiology because this study was designed to ensure that it didnt over enroll for men, and not and have the purposeful inclusion of women to be well-represented, and so they did cap at 70% enrollment for men
#Research #InternalMedicine #MedEd To view or add a comment, sign in Metabolic Medicine & Cardiovascular Health Metabolic treatments have pivoted heavily toward disease reversal rather than just blood-sugar management, with popular GLP-1 medications significantly lowering the risk of heart failure hospitalizations
Federal law prohibits Medicare from covering drugs solely for weight loss, meaning GLP-1s are only reimbursed under Part D for other approved indications, like type 2 diabetes, cardiovascular risk reduction, MASH, or sleep apnea
Clinical trials show that the highest dose of Wegovy, 7.2 mg per week, is the most effective dose for weight loss
They help regulate blood sugar, insulin response, appetite, fullness, and digestion